OCT 26, 2026 · JOURNAL ARTICLE
Immunohistochemical Subtype Conversion and Pathological Response After Neoadjuvant Chemotherapy in Luminal B HER2-Negative Locally Advanced Breast Cancer: A Cross-Sectional Study
Bioscientia Medicina Journal of Biomedicine and Translational Research
Background: Luminal B HER2-negative breast cancer responds only modestly to neoadjuvant chemotherapy (NAC), and the receptor profile of its residual tumor may differ from that of t